ABBV
Price
$181.97
Change
+$1.61 (+0.89%)
Updated
Mar 28, 6:59 PM EST
27 days until earnings call
MRK
Price
$131.92
Change
+$0.12 (+0.09%)
Updated
Mar 28, 6:59 PM EST
27 days until earnings call
Ad is loading...

Compare trend and price ABBV vs MRK

Header iconABBV vs MRK Comparison
Open Charts ABBV vs MRKBanner chart's image
ABBVIE
Price$181.97
Change+$1.61 (+0.89%)
Volume$1.04M
CapitalizationN/A
Merck & Co
Price$131.92
Change+$0.12 (+0.09%)
Volume$2.34M
CapitalizationN/A
View a ticker or compare two or three
ABBV vs MRK Comparison Chart

Loading...

ABBVDaily Signal changed days agoGain/Loss if shorted
 
Show more...
MRKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ABBV vs. MRK commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABBV is a Hold and MRK is a Hold.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (ABBV: $182.10 vs. MRK: $131.95)
Brand notoriety: ABBV and MRK are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: ABBV: 95% vs. MRK: 117%
Market capitalization -- ABBV: $322.43B vs. MRK: $334.18B
ABBV [@Pharmaceuticals: Major] is valued at $322.43B. MRK’s [@Pharmaceuticals: Major] market capitalization is $334.18B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $87.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABBV’s FA Score shows that 5 FA rating(s) are green whileMRK’s FA Score has 3 green FA rating(s).

  • ABBV’s FA Score: 5 green, 0 red.
  • MRK’s FA Score: 3 green, 2 red.
According to our system of comparison, ABBV is a better buy in the long-term than MRK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABBV’s TA Score shows that 4 TA indicator(s) are bullish while MRK’s TA Score has 5 bullish TA indicator(s).

  • ABBV’s TA Score: 4 bullish, 3 bearish.
  • MRK’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ABBV is a better buy in the short-term than MRK.

Price Growth

ABBV (@Pharmaceuticals: Major) experienced а +2.59% price change this week, while MRK (@Pharmaceuticals: Major) price change was +6.74% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.67%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was -2.01%.

Reported Earning Dates

ABBV is expected to report earnings on Apr 25, 2024.

MRK is expected to report earnings on Apr 25, 2024.

Industries' Descriptions

@Pharmaceuticals: Major (+0.67% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
A.I.dvisor published
a Summary for ABBV with price predictions.
OPEN
A.I.dvisor published
a Summary for MRK with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
MRK($334B) and ABBV($322B) have the same market capitalization . MRK has higher P/E ratio than ABBV: MRK (942.50) vs ABBV (66.95). MRK YTD gains are higher at: 21.801 vs. ABBV (18.629). ABBV has higher annual earnings (EBITDA): 17.2B vs. MRK (6.91B). ABBV has more cash in the bank: 12.8B vs. MRK (7.09B). MRK has less debt than ABBV: MRK (35.1B) vs ABBV (59.4B). MRK has higher revenues than ABBV: MRK (60.1B) vs ABBV (54.3B).
ABBVMRKABBV / MRK
Capitalization322B334B96%
EBITDA17.2B6.91B249%
Gain YTD18.62921.80185%
P/E Ratio66.95942.507%
Revenue54.3B60.1B90%
Total Cash12.8B7.09B180%
Total Debt59.4B35.1B169%
FUNDAMENTALS RATINGS
ABBV vs MRK: Fundamental Ratings
ABBV
MRK
OUTLOOK RATING
1..100
1512
VALUATION
overvalued / fair valued / undervalued
1..100
11
Undervalued
90
Overvalued
PROFIT vs RISK RATING
1..100
45
SMR RATING
1..100
2889
PRICE GROWTH RATING
1..100
2520
P/E GROWTH RATING
1..100
71
SEASONALITY SCORE
1..100
5038

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ABBV's Valuation (11) in the Pharmaceuticals Major industry is significantly better than the same rating for MRK (90). This means that ABBV’s stock grew significantly faster than MRK’s over the last 12 months.

ABBV's Profit vs Risk Rating (4) in the Pharmaceuticals Major industry is in the same range as MRK (5). This means that ABBV’s stock grew similarly to MRK’s over the last 12 months.

ABBV's SMR Rating (28) in the Pharmaceuticals Major industry is somewhat better than the same rating for MRK (89). This means that ABBV’s stock grew somewhat faster than MRK’s over the last 12 months.

MRK's Price Growth Rating (20) in the Pharmaceuticals Major industry is in the same range as ABBV (25). This means that MRK’s stock grew similarly to ABBV’s over the last 12 months.

MRK's P/E Growth Rating (1) in the Pharmaceuticals Major industry is in the same range as ABBV (7). This means that MRK’s stock grew similarly to ABBV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABBVMRK
RSI
ODDS (%)
Bearish Trend 1 day ago
48%
Bearish Trend 1 day ago
60%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
48%
Bearish Trend 1 day ago
54%
Momentum
ODDS (%)
Bullish Trend 1 day ago
68%
Bullish Trend 1 day ago
52%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
59%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
54%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
47%
Advances
ODDS (%)
Bullish Trend 1 day ago
59%
Bullish Trend 1 day ago
50%
Declines
ODDS (%)
Bearish Trend 22 days ago
47%
Bearish Trend 16 days ago
45%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
47%
Bearish Trend 1 day ago
41%
Aroon
ODDS (%)
Bullish Trend 1 day ago
69%
Bearish Trend 1 day ago
46%
View a ticker or compare two or three
Ad is loading...
ABBVDaily Signal changed days agoGain/Loss if shorted
 
Show more...
MRKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GOGO8.770.10
+1.15%
Gogo
MPLX41.560.25
+0.61%
Mplx LP
TEX64.40-0.12
-0.19%
Terex Corp
ORN8.20-0.10
-1.20%
Orion Group Holdings
CPSH1.85-0.03
-1.60%
CPS Technologies Corp

ABBV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABBV has been loosely correlated with PFE. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ABBV jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABBV
1D Price
Change %
ABBV100%
+0.97%
PFE - ABBV
54%
Loosely correlated
-0.11%
JNJ - ABBV
37%
Loosely correlated
+0.15%
MRK - ABBV
33%
Loosely correlated
+0.15%
AMGN - ABBV
32%
Poorly correlated
-0.72%
AZN - ABBV
28%
Poorly correlated
-0.79%
More

MRK and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRK has been loosely correlated with NVS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if MRK jumps, then NVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRK
1D Price
Change %
MRK100%
+0.15%
NVS - MRK
44%
Loosely correlated
+0.89%
JNJ - MRK
43%
Loosely correlated
+0.15%
GSK - MRK
39%
Loosely correlated
-0.28%
AZN - MRK
37%
Loosely correlated
-0.79%
BMY - MRK
33%
Poorly correlated
+1.84%
More